Inhibition of Plasmepsin V activity demonstrates its essential role in protein export, PfEMP1 display, and survival of malaria parasites.
Inhibition of Plasmepsin V activity demonstrates its essential role in protein export, PfEMP1 display, and survival of malaria parasites.
复制标题
DOI:
10.1371/journal.pbio.1001897
复制
发表时间:
2014-07
期刊:
影响因子:
9.8
通讯作者:
Boddey JA
中科院分区:
文献类型:
--
作者:
Sleebs BE;Lopaticki S;Marapana DS;O'Neill MT;Rajasekaran P;Gazdik M;Günther S;Whitehead LW;Lowes KN;Barfod L;Hviid L;Shaw PJ;Hodder AN;Smith BJ;Cowman AF;Boddey JA
A small molecule inhibitor of the malarial protease Plasmepsin V impairs protein export and cellular remodeling, reducing parasite survival in human erythrocytes. The malaria parasite Plasmodium falciparum exports several hundred proteins into the infected erythrocyte that are involved in cellular remodeling and severe virulence. The export mechanism involves the Plasmodium export element (PEXEL), which is a cleavage site for the parasite protease, Plasmepsin V (PMV). The PMV gene is refractory to deletion, suggesting it is essential, but definitive proof is lacking. Here, we generated a PEXEL-mimetic inhibitor that potently blocks the activity of PMV isolated from P. falciparum and Plasmodium vivax. Assessment of PMV activity in P. falciparum revealed PEXEL cleavage occurs cotranslationaly, similar to signal peptidase. Treatment of P. falciparum–infected erythrocytes with the inhibitor caused dose-dependent inhibition of PEXEL processing as well as protein export, including impaired display of the major virulence adhesin, PfEMP1, on the erythrocyte surface, and cytoadherence. The inhibitor killed parasites at the trophozoite stage and knockdown of PMV enhanced sensitivity to the inhibitor, while overexpression of PMV increased resistance. This provides the first direct evidence that PMV activity is essential for protein export in Plasmodium spp. and for parasite survival in human erythrocytes and validates PMV as an antimalarial drug target. To survive within human red blood cells, malaria parasites must export a catalog of proteins that remodel the host cell and its surface. This enables parasites to acquire nutrients from outside the cell and to modify the cell surface in order to evade host defenses. Protein export involves proteolytic cleavage of the Plasmodium Export Element (PEXEL) by the aspartyl protease Plasmepsin V. We report here the development of a small molecule inhibitor that closely mimics the natural PEXEL substrate and blocks the activity of Plasmepsin V from the malarial parasites Plasmodium falciparum and Plasmodium vivax. The inhibitor impairs export and cellular remodeling and kills P. falciparum at the ring-trophozoite transition, providing direct evidence that Plasmepsin V activity is essential for export of PEXEL proteins and parasite survival within the host. These findings validate Plasmepsin V as a highly conserved antimalarial drug target.
登录
查看更多内容
影响因子:
1.5
作者:
Deponte, Marcel;Hoppe, Heinrich C.;Przyborski, Jude M.
通讯作者:
Przyborski, Jude M.
DOI:
10.4269/ajtmh.2001.64.97
发表时间:
2001-01-01
影响因子:
3.3
作者:
Mendis, K;Sina, BJ;Carter, R
通讯作者:
Carter, R
DOI:
10.1111/tra.12049
发表时间:
2013-05
期刊:
Traffic (Copenhagen, Denmark)
影响因子:
--
作者:
Hsiao CH;Luisa Hiller N;Haldar K;Knoll LJ
通讯作者:
Knoll LJ
影响因子:
64.5
作者:
Maier AG;Rug M;O'Neill MT;Brown M;Chakravorty S;Szestak T;Chesson J;Wu Y;Hughes K;Coppel RL;Newbold C;Beeson JG;Craig A;Crabb BS;Cowman AF
通讯作者:
Cowman AF
影响因子:
120.1
作者:
Drag, Marcin;Salvesen, Guy S.
通讯作者:
Salvesen, Guy S.